Brief: Champions Biotechnology reports Q1 loss per share $0.06

Champions Oncology

14/09/2017 21:31

Sept 15 (Reuters) - Champions Biotechnology Inc  CSBR.O  
    * Champions Oncology reports record quarterly revenue of $5 
million 
    * Q1 revenue rose 37.1 percent to $5.0 million 
    * Sees fy 2018 revenue up at least 20 percent 
    * Champions Biotechnology Inc - reiterated expectations for 
fiscal year 2018 revenue growth of at least 20 pct over fiscal 
year 2017 
    * Champions Biotechnology Inc qtrly loss per share $0.06 
    * Champions Biotechnology Inc qtrly adjusted loss per share 
$0.01 
 
Source text for Eikon:  ID:nPn248Jlka  
Further company coverage:  CSBR.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))